| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/19/2008 | CN100375630C Compound drop pills with flavescent sophora root and its preparation method |
| 03/19/2008 | CN100375629C Pilose antler-glossy ganoderma capsule |
| 03/19/2008 | CN100375626C Chinese medicine compound preparation for treating depression and its preparation method |
| 03/19/2008 | CN100375625C Quick thrombolysis for apoplexy |
| 03/19/2008 | CN100375622C Freeze dried powder injection of cytarabine and its preparation process |
| 03/19/2008 | CN100375621C Vinorelbine liposome micro ball injection and its preparation method |
| 03/19/2008 | CN100375618C High performance composite hollow konjaku capsule and its preparation process |
| 03/19/2008 | CN100375617C Liquid capsule and production method thereof |
| 03/19/2008 | CN100375616C Bone strengthening dripping pills with Premena fulva craib as raw material and method for preparing the same |
| 03/19/2008 | CN100375615C Compound drop pills of stramonium and its preparation method |
| 03/19/2008 | CN100375614C Dripping pills with jaundice eliminating liver protecting functions and its preparation method |
| 03/19/2008 | CN100375613C Schizandrol dripping pills for decreasing aminopherase and method for preparing the same |
| 03/19/2008 | CN100375612C Blood pressure lowering dripping pills with chryanthemum flower and pearl and its preparation process |
| 03/19/2008 | CN100375611C Dripping pills of rheocamphoradin and its preparation process |
| 03/19/2008 | CN100375610C Dripping pills of honey suckle and its preparation method |
| 03/19/2008 | CN100375609C Dripping pills of emblic leafflower fruit and its preparation process |
| 03/19/2008 | CN100375608C Tortoise-astragalus root-ginseng dripping pill and its preparing method |
| 03/18/2008 | US7345138 Biodegradable polyphosphates for controlled release of bioactive substances |
| 03/18/2008 | US7345093 Methods of enhancing solubility of compounds |
| 03/18/2008 | US7345024 Pharmaceutical preparation, method for its production as well as its use |
| 03/18/2008 | US7345023 Treatment of hyperproliferative conditions of body surfaces |
| 03/18/2008 | US7344887 Methods and products for delivering biological molecules to cells using multicomponent nanostructures |
| 03/18/2008 | US7344738 Cancer, human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), immune deficient symptoms of old age, chronic fatigue syndrome, and allergies |
| 03/18/2008 | US7344737 Herbal composition for cuts, burns and wounds |
| 03/18/2008 | US7344736 Extraction of pharmaceutically active components from plant materials |
| 03/18/2008 | US7344734 Controlling particle size; antiagglomerant |
| 03/18/2008 | US7344733 Matrix controlled transdermal therapeutic system for the use of pramipexole and ropinirole |
| 03/18/2008 | US7344732 Tampon body manufactured at first manufacturing facility and dosage form coupled to body, dosage form includes therapeutic agent manufactured at second facility |
| 03/18/2008 | US7344725 Use of inorganic nanoparticles to stabilize hydrogen peroxide solutions |
| 03/18/2008 | US7344713 Decreased fat absorption with an anti-lipase antibody |
| 03/18/2008 | US7344705 Composition comprising low density microspheres |
| 03/18/2008 | US7344490 System for administering a combination of therapies to a body lumen |
| 03/18/2008 | US7344047 Automatic medicament dispenser system |
| 03/18/2008 | US7343915 Apparatus and method for self-induced cough cardiopulmonary resuscitation |
| 03/18/2008 | CA2507743C Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles |
| 03/18/2008 | CA2454328C Pharmaceutical combinations of oxycodone and naloxone |
| 03/18/2008 | CA2415849C Pharmaceutical powder cartridge, and inhaler equipped with same |
| 03/18/2008 | CA2401005C Methods for extraction and reaction using supercritical fluids |
| 03/18/2008 | CA2389167C Pharmaceutical formulations of resveratrol and methods of use thereof |
| 03/18/2008 | CA2382359C Pharmaceutical preparation containing nanosol |
| 03/18/2008 | CA2379331C Ectoparasiticidal aqueous suspension formulations of spinosyns |
| 03/18/2008 | CA2355776C Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents |
| 03/18/2008 | CA2355239C Pharmaceutical formulations |
| 03/18/2008 | CA2355186C Process for producing polymer |
| 03/18/2008 | CA2347195C Oral pharmaceutical compositions containing buprenorphin |
| 03/18/2008 | CA2341976C Fish gelatinous composition for use as an ingredient in tablets |
| 03/18/2008 | CA2335928C Compositions biphasiques injectables, notamment utiles en chirurgies reparatrice et esthetique |
| 03/18/2008 | CA2335015C Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug |
| 03/18/2008 | CA2329128C Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 03/18/2008 | CA2323839C Treatment of neuropathy |
| 03/18/2008 | CA2320430C Recombinant mistletoe lectins |
| 03/18/2008 | CA2319359C Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers |
| 03/18/2008 | CA2315927C Oral pharmaceutical pulsed release dosage form |
| 03/18/2008 | CA2303852C Fish gelatin compositions containing a hydrocolloid setting system |
| 03/18/2008 | CA2275889C Formulation and method for treating neoplasms by inhalation |
| 03/18/2008 | CA2275663C Pharmaceutical compositions comprising .alpha.-adrenergic agonists for the treatment of fecal incontinence |
| 03/18/2008 | CA2269319C Improvements in or relating to contrast agents |
| 03/18/2008 | CA2266645C Polycarboxylic based cross-linked copolymer |
| 03/18/2008 | CA2258878C Liposomal influenza vaccine composition and method |
| 03/18/2008 | CA2211677C Taste masking liquids |
| 03/18/2008 | CA2193235C The preparation of fusidic acid tablets |
| 03/18/2008 | CA2181073C Tissue-specific enhancer active in prostate |
| 03/18/2008 | CA2167980C Cgrp antagonist used in a cosmetic composition; pharmaceutical or dermatologic composition produced |
| 03/18/2008 | CA2102494C A pharmaceutical composition containing a defined lipid system |
| 03/14/2008 | CA2568354A1 Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof |
| 03/13/2008 | WO2008031108A2 Sol-gel precursors and products thereof |
| 03/13/2008 | WO2008031035A2 Engineering shape of polymeric micro-and nanoparticles |
| 03/13/2008 | WO2008030949A2 Stable polyunsaturated fatty acid emulsions and methods for inhibitintg, suppressing, or reducing degradation of polyunsaturated fatty acids in an emulsion |
| 03/13/2008 | WO2008030830A2 Sustained-release composition and method of use thereof |
| 03/13/2008 | WO2008030818A2 Novel liposome compositions |
| 03/13/2008 | WO2008030807A2 Phosphatidylethanolamine derivative and liposome containing the same |
| 03/13/2008 | WO2008030591A2 Peham dendrimers as excipients |
| 03/13/2008 | WO2008030567A2 Dry powder compound formulations and uses thereof |
| 03/13/2008 | WO2008030557A2 Compositions and methods for enhancing transport through mucus |
| 03/13/2008 | WO2008030512A2 Polystyrene sulfonate polymer tablets, their preparation and use |
| 03/13/2008 | WO2008030473A2 Process for forming nanoparticles by micellization of blocky copolymers in subcritical and supercritical solvents |
| 03/13/2008 | WO2008030469A2 Soft chewable, tablet, and long-acting injectable veterinary antibiotic formulations |
| 03/13/2008 | WO2008030134A1 Method for producing microcapsulated medicinal substances in the form of micronised water-dispersible powders and pastes |
| 03/13/2008 | WO2008029909A1 Composition comprising reduced coenzyme q10 and lysolecithin |
| 03/13/2008 | WO2008029908A1 Stable lyophilized pharmaceutical preparation comprising antibody |
| 03/13/2008 | WO2008029897A1 Endotoxin absorbent for preventing or treating autoimmune disease |
| 03/13/2008 | WO2008029763A1 Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent |
| 03/13/2008 | WO2008029599A1 Magnetic particles and process for their production |
| 03/13/2008 | WO2008029417A2 Pharmaceutical formulation for use in hiv therapy |
| 03/13/2008 | WO2008029401A1 Nucleation in liquid, methods of use thereof and methods of generation thereof |
| 03/13/2008 | WO2008029351A2 A modified release formulation comprising amoxicillin and clavulanate |
| 03/13/2008 | WO2008029310A2 Delivery systems for delivering functional compounds to substrates and processes of using the same |
| 03/13/2008 | WO2008029282A2 Aqueous formulation comprising an antitumor agent |
| 03/13/2008 | WO2008029264A2 Method of treating bone cancer |
| 03/13/2008 | WO2008029208A1 Use of polyols to obtain stable polymorphous forms of rifaximin |
| 03/13/2008 | WO2008028885A2 Composition comprising an angiotensin ii receptor antagonist |
| 03/13/2008 | WO2008028602A2 Chewing gum preparations comprising physiological agents |
| 03/13/2008 | WO2008028547A1 Liquid composition for prevention and/or treatment of different bone metabolic diseases, uses thereof, and preparation process therefore |
| 03/13/2008 | WO2008028410A1 Use of low molecular weight fucoidan in the preparation of medicament for the treatment of cardiovascular and cerebrovascular diseases |
| 03/13/2008 | WO2008028347A1 Combined antibiotics preparation |
| 03/13/2008 | WO2008028324A1 Novel levamisole formulation for allergic rhinitis |
| 03/13/2008 | WO2008028300A1 Oral polymeric membrane feruloyl esterase producing bacteria formulation |
| 03/13/2008 | WO2008028264A1 Process for the production of micro-capsules having magnetic properties, product obtained therefrom and method for the controlled release of active substances |
| 03/13/2008 | WO2008013757A3 Delivery system and method of manufacturing the same |
| 03/13/2008 | WO2008012071A3 Pharmaceutical compositions of nicotine and methods of use thereof |